Therefore, based on our current large-scale analysis, realized in 152 malignant breast tissues and in 38 non-cancerous and cancerous breast cell lines, and by using a more sensitive and specific method (qRT-PCR) [55], we currently present PKD1 as a new pertinent marker for breast cancer invasion. This evidence concerns the gene PKD1 and medical procedure.